B | |||||
---|---|---|---|---|---|
Variable | Remicade® (n = 28) | Inflectra® (n = 55) | P-value | ||
Exacerbation | 75% | 21 | 64% | 34 | 0.64 |
Repeated biological treatment | 21% | 6 | 17% | 9 | 0.83 |
Exacerbation < 6 months | 67% | 14 | 62% | 21 | 0.86 |
Referral for colectomy | 25% | 7 | 23% | 12 | 0.90 |
B | |||||
---|---|---|---|---|---|
Variable | Remicade® (n = 28) | Inflectra® (n = 55) | P-value | ||
Exacerbation | 75% | 21 | 64% | 34 | 0.64 |
Repeated biological treatment | 21% | 6 | 17% | 9 | 0.83 |
Exacerbation < 6 months | 67% | 14 | 62% | 21 | 0.86 |
Referral for colectomy | 25% | 7 | 23% | 12 | 0.90 |